Stephen F. Betz - Nov 15, 2021 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Scientific Officer
Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Nov 15, 2021
Transactions value $
-$193,574
Form type
4
Date filed
11/17/2021, 04:01 PM
Previous filing
Nov 9, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common stock Sale -$152K -5.67K -3.5% $26.75 156K Nov 15, 2021 Direct F1
transaction CRNX Common Stock Sale -$42K -1.5K -0.96% $27.97 155K Nov 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.